http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105693818-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9143d591593f4c33f9beb0d875abe209
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-083
filingDate 2016-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_437a28e67f253a4551fee9c457bc43bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32be6425cf8cd155f3b4360d46020e54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db6134ddeda1de671aec9a2c2f58f8da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_938671e5a3909d7677cbe29b21893e82
publicationDate 2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105693818-A
titleOfInvention Glycine-L-cysteine-L-phenylalanine tripeptide and application thereof to preparation of medicines for treating stroke
abstract The invention belongs to the field of medicines and provides application of a glycine-L-cysteine-L-phenylalanine tripeptide to preparation of medicines for treating stroke.According to animal experiments, by means of intravenous administration, the tripeptide penetrates blood brain barriers to enter brain tissues and cells so as to evidently reduce cerebral infarction volume of rats, and a stroke treatment function is realized.The glycine-L-cysteine-L-phenylalanine tripeptide available for conventional intravenous administration is functionally superior to existing clinical medicines.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106279358-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108201515-A
priorityDate 2016-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID128239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID978331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416106027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415826801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733084
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451218358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415792633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421109490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453134186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414804309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6456

Total number of triples: 52.